Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verho

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Infection|May 1, 1987
Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivativeV Malerczyk, L Maass, M Verho, et al.
Infection|May 1, 1987
Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivateL Maass, V Malerczyk, M Verho, et al.
Pharmaceutical Research|August 1, 1988
Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high dosesH Möllmann, P Rohdewald, J Barth, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Piretanide, a potassium stable diuretic, in the treatment of essential hypertensionM Verho, B Rangoonwala, W Dols, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Piretanide in the treatment of essential hypertension. A double-blind comparison versus placeboM Verho, B Rangoonwala, M Beloso, et al.
Current Medical Research and Opinion|August 15, 1998
Effects of felodipine ER, a dihydropyridine calcium antagonist, on blood pressure and serum lipidsM K Reuter, H Lorenz, P Verho, et al.
Clinical Therapeutics|January 1, 1986
Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agentE E Dagrosa, M Verho, V Malerczyk, et al.
Pharmatherapeutica|January 1, 1985
Renal tolerance of ofloxacin, a new gyrase inhibitorM Verho, E E Dagrosa, P Usinger, et al.
Chemotherapy|January 1, 1988
Safety, tolerance and pharmacokinetics of 2.0 g cefpirome (HR 810) after single and multiple dosingM Badian, V Malerczyk, J D Collins, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Multiple-dose pharmacokinetics of ramipril in patients with chronic congestive heart failureB Heintz, M Verho, D Brockmeier, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Infection|May 1, 1987
Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivativeV Malerczyk, L Maass, M Verho, et al.
Infection|May 1, 1987
Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivateL Maass, V Malerczyk, M Verho, et al.
Pharmaceutical Research|August 1, 1988
Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high dosesH Möllmann, P Rohdewald, J Barth, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Piretanide, a potassium stable diuretic, in the treatment of essential hypertensionM Verho, B Rangoonwala, W Dols, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Piretanide in the treatment of essential hypertension. A double-blind comparison versus placeboM Verho, B Rangoonwala, M Beloso, et al.
Current Medical Research and Opinion|August 15, 1998
Effects of felodipine ER, a dihydropyridine calcium antagonist, on blood pressure and serum lipidsM K Reuter, H Lorenz, P Verho, et al.
Clinical Therapeutics|January 1, 1986
Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agentE E Dagrosa, M Verho, V Malerczyk, et al.
Pharmatherapeutica|January 1, 1985
Renal tolerance of ofloxacin, a new gyrase inhibitorM Verho, E E Dagrosa, P Usinger, et al.
Chemotherapy|January 1, 1988
Safety, tolerance and pharmacokinetics of 2.0 g cefpirome (HR 810) after single and multiple dosingM Badian, V Malerczyk, J D Collins, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Multiple-dose pharmacokinetics of ramipril in patients with chronic congestive heart failureB Heintz, M Verho, D Brockmeier, et al.
Pageof 6